John Valliant's Net Worth
John Valliant's net worth is estimated to be at least $517,191.81 as of 05/01/2024. CoreStreet's estimation of John Valliant's net worth is based on their sale of stock and current holding of stock.
John Valliant is CEO at Fusion Pharmaceuticals Inc. They have executed at least 20 trades of stock as per SEC Form 4 filings. Their most recent trade was for 4,511 units of FUSN stock on 04/27/2022. Their biggest sale was on 02/15/2022 when they sold 12,600 units of Fusion Pharmaceuticals Inc stock for $104,958.00. They typically trade 20 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $517,191.81
Most recent insider trade:
- April 27, 2022
John Valliant's Insider Trading History
| Fusion Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 27, 2022 | CEO | 4,511 | $6.03 | Sell | $27,201.33 |
April 25, 2022 | CEO | 2,036 | $6.03 | Sell | $12,277.08 |
April 20, 2022 | CEO | 367 | $6.02 | Sell | $2,209.34 |
April 13, 2022 | CEO | 11,994 | $6.41 | Sell | $76,881.54 |
April 11, 2022 | CEO | 2,600 | $7.37 | Sell | $19,162.00 |
April 8, 2022 | CEO | 826 | $7.52 | Sell | $6,211.52 |
April 6, 2022 | CEO | 100 | $7.58 | Sell | $758.00 |
March 30, 2022 | CEO | 300 | $7.52 | Sell | $2,256.00 |
March 28, 2022 | CEO | 9,600 | $7.55 | Sell | $72,480.00 |
March 25, 2022 | CEO | 500 | $7.42 | Sell | $3,710.00 |
March 23, 2022 | CEO | 100 | $7.50 | Sell | $750.00 |
March 21, 2022 | CEO | 1,500 | $7.47 | Sell | $11,205.00 |
March 17, 2022 | CEO | 900 | $7.51 | Sell | $6,759.00 |
March 7, 2022 | CEO | 3,100 | $6.99 | Sell | $21,669.00 |
March 4, 2022 | CEO | 8,400 | $7.32 | Sell | $61,488.00 |
Feb. 28, 2022 | CEO | 3,100 | $7.40 | Sell | $22,940.00 |
Feb. 24, 2022 | CEO | 2,500 | $7.41 | Sell | $18,525.00 |
Feb. 22, 2022 | CEO | 4,100 | $7.85 | Sell | $32,185.00 |
Feb. 17, 2022 | CEO | 1,700 | $7.98 | Sell | $13,566.00 |
Feb. 15, 2022 | CEO | 12,600 | $8.33 | Sell | $104,958.00 |